SlideShare ist ein Scribd-Unternehmen logo
1 von 67
AMANDEEP KAUR
MMCON
Lung Cancer
Respiratory system.
Organs of respiratiory system
 Upper respiratory tracts
 Nose
 Pharynx
 Larynx
 Trachea
 Lower respiratory tracts
 Two bronchi (one bronchus to each lung) Bronchioles
and smaller air passage
 Two lungs and their covering pleura
Normal Physiology Of Respiration
 Normal respiration begins by inhaling air through the
mouth and nose.
 This air flows down into trachea, which divides into
the left and right bronchi, and then to the alveoli.
 The alveoli are responsible for oxygenating the blood
for circulation as well as removing carbon dioxide
from the blood.
Lung Cancer
 Most common cause of cancer death for men
and women.
 Tobacco use accounts for 87% of lung cancer.
 Lung cancer affect primarily in 5 or 6th decade
of life.
 In 70% of lung cancer patient , disease has
spread to distant organs.
Definition
 Cancer: An abnormal growth of cells which tend to
proliferate in an uncontrolled way and, in some cases,
to metastasize (spread). Cancer is not one disease. It
is a group of more than 100 different and distinctive
diseases.
Healthy Lung Tissue
Diseased Lung Tissue
Types of Lung Cancer
Two main Types of Lung Cancer:
Small Cell Lung Cancer (20-25% of all lung cancers)
Non Small Cell Lung Cancer (most common
~80%)
Small Cell Lung Cancer
 Small Cell Lung Cancer is the most aggressive
form of lung cancer.
 It usually starts in the bronchi and then effects the
whole lung.
 These cancer cells are small and are considered to
be quite aggressive in nature and they have a large
growth factors.
Contd..
 Because of these reasons, at the time of
diagnosis, (60% of the time), these tumors have
often metastasize to other parts of the body
(brain, liver, and bone marrow)
 SCLC accounts for 20-25% of all lung cancers.
Contd..
Non Small Cell Lung Cancer
 NSCLC is any type of epithelial lung cancer
other than small cell lung cancer.
 Non-small cell lung Ca usually grows and
spreads more slowly than SCLC.
Types of NSCL
 Squamous cell carcinomas usually arise centrally in
larger bronchi
 Adenocarcinoma : formed from grandular structure in
epithelial tissues (mucus secreting glands) are often found
in the periphery of the lungs
 Large cell carcinomas can occur in any part of the lung
and tend to grow and spread faster than the other two
types
Squamous Cell Carcinoma
 Moderate to poor differentiation
 Makes up 30-40% of all lung cancers
 More common in males
 Most occur centrally in the large bronchi
 Uncommon metastasis that is slow effects the liver,
adrenal glands and lymph nodes.
 Associated with smoking
 Not easily visualized on x-ray.
Adenocacinoma
 Increasing in frequency. Most common type
of Lung cancer (40-50% of all lung cancers).
 Clearly defined peripheral lesions
 Glandular appearance under a microscope
 Easily seen on a CXR
 Can occur in non-smokers
 Slow metastatic in nature
 Pts present with or develop brain,
Liver, adrenal or bone metastasis
Large Cell Carcinomas
 Makes up 15-20% of all lung cancers
 Poorly differentiated cells
 Tends to occur in the outer part (periphery) of lung,
invading sub-segmental bronchi or larger airways
 Metastasis is slow BUT
 Early metastasis occurs to the kidney, liver organs as
well as the adrenal glands.
Causes and risk factors
 Gender
 Smoking history
Active smoking=85-87%
Passive smoking=3-5%
 Older age
 Presence of airflow obstruction
 Genetic predisposition.
Cont...
 Pollution and occupational exposure
 Industry work due to asbestos(heat resistant fibrous).
 Lung Disease like T.B
 family History
 Diet (low in fruits and vegetables)
Patho-physiology
Carcinogens like smoking, occupational and
environmental agents, genetics.
Binds with cell’s DNA and damage the cells.
Cellular changes and abnormal cell growth
occur.
Cont...
Malignant transformation of pulmonary epithelial
cells.
Abnormal proliferation of the lung cell. These
cells grow slowly and covers the segmental
bronchi and lobes of the lung.
Non specific inflammatory changes with
hypersecretion of mucus, desquamation of the
cells.
Cont...
Lesions formation in the lung’s tissues involving
the bronchi, bronchioles or even alveoli
Bronchogenic carcinoma.
Signs and Symptoms
There are two types of signs and symptoms of
lung cancer:
1) Localized – involving the lung.
2) Generalized – involves other areas throughout
the body if the cancer has spread.
Localized Signs and Symptoms
 Cough and fatigue
 Breathing Problems, stridor
 blood in phlegm
 Lung infection, hemoptysis
 Hoarseness, Hiccups
 Weight loss
 Chest Pain and tightness
 Pleural Effusion
Generalized Signs and Symptoms
 Bone pain
 Headaches, mental status changes or neurologic
findings
 Abdominal pain, elevated liver function tests,
enlarged liver, gastrointestinal disturbances
(anorexia, cachexia), jaundice, hepatomegaly
 Weight loss
Early/late Signs and Symptoms Of Lung
Cancer
Early Signs Late signs
Cough/chronic cough Bone pain, spinal cord compression
Dyspnea Chest pain/tightness
Hemoptysis Dysphagia
Chest/shoulder pain Head and neck edema
Recurring temperature Blurred vision, headaches
Recurring respiratory
infections
Weakness, anorexia, weight-loss,
cachexia
Pleural effusion
Liver metastasis/regional spread
Diagnostic Tests
 CXR
 CT Scans
 MRI
 Sputum cytology
 Fibreoptic bronchoscopy
 Transthoracic fine needle aspiration
Laboratory Tests
Blood Tests
*CBC- to check red/white blood cell & platelets
-to check bone marrow and organ function
*Blood Chemistry Test- to assess how organs are
functioning such as liver and kidney
Biopsy-to determine if the tumor is cancer or not
-to determine the type of cancer
-to determine the grade of cancer (slow
or fast)
Bronchoscopy
 Endoscopy
 Mediastinoscopy
 VATS (video assisted thoracoscopic surgery)
Mediastinoscopy
VATS (Video Assisted
Thoracoscopic Surgery)
Nursing Management for post endoscopic
procedures
Bronchoscopy Mediastinoscopy VATS
Monitor V/S; NPO
status maintained
until return of gag
reflex.
(Fever up to 1010F
can be expected
afterwards).
Monitor VS;
potential for
bleeding, infection
and dyspnea; NPO
status until return
of gag reflex
Monitor V/S;
potential for
bleeding,
infection and
dyspnea; NPO
status until return
of gag reflex
Post-op complications for those
with lung cancer
 Airway obstruction, dyspnea, hypoxemia, respiratory failure
 Anesthesia side effects (N/V)
 Bleeding (hypotension, cardiogenic shock)
 Cardiac dysthymias, CHF, fluid overload
 Fever, sepsis
 Pneumonia
 Pneumothorax
 Pulmonary embolus
 Wound dehiscence
 Prolonged hospitalization
 Death
Cancer Staging Systems
 The most common staging system for lung cancer is
the TNM System developed by the International
Union Against Cancer (UICC).
 Guides best course of treatment
 Estimates prognosis
 It is only useful in staging NSCLC, when surgery is
considered.
TMN Staging system for Lung Cancer
T= Tumors : tumor size,
(local invasion)
N= Node : node involvement
(size and type)
M= Metastasis : general
involvement in organs and
tissues
Tumor size
 Tx – The tumor size is unknown, or cancer cells are
only found in sputum.
 T0 – The tumor is present only in the cells lining the
airway
 T1 – Tumors less than or equal to 3 cm
 T2- Tumors size is 4-7 cm.
 T3 – Tumors greater than 7 cm
T4 – tumor that invades structures in the chest such
as the heart, major blood vessels near the heart, the
trachea, the esophagus.
Nodal involvement
 N0 – No nodes are involved.
 N1 – The tumor has spread to nearby nodes on the same
side of the body.
 N2 – The tumor has spread to nodes farther away, but
on the same side of the chest.
 N3 – The tumor has spread to lymph nodes on the other
side of the chest from the original tumor, or has spread
to nodes near the collarbone or neck muscles.
Metastasis
 M0 - The tumor has not spread to distant regions.
 M1:
 M1a – The tumor has spread to the opposite
lung, to the lung lining
 M1b – The tumor has spread to distant regions
of the body, such as the brain or bones.
Staging
Stage 1. Tumor is small and localised to lung, no lymph
node involvement
 A-Tumor <3 cm
 B-Tumor >3 cm and invading surrounding local area
Stage 2.
 A-Tumor <3cm with invasion of lymph nodes.
 Tumor >3 cm involving the bronchus and lymph nodes
on the same side of chest and tissue of local organs.
Contd..
Stage 3.
 A. Tumor spread to the nearby structure and
regional lymph nodes
 B. Tumor involving heart, trachea, esophagus,
mediastinum and lymph nodes.
Stage 4- distant metastasis
Medical Management
The three main cancer treatments are:
*surgery (lung resections)
*Radiation therapy
*chemotherapy
Other types of treatment that are used to treat certain
cancers are hormonal therapy, biological therapy or
stem cell transplant.
Surgical treatment
 Lobectomy: a single lobe of lung is removed
 Bilobectomy: 2 lobes of the lung are removed (only on R
side)
 Sleeve resection: cancerous lobe is removed and segment
of the main bronchus is resected
 Pneumonectomy: removal of entire lung
 Segmentectomy: a segment of the lung is removed
 Wedge resection: removal of a small, pie-shaped area of
the segment
 Chest wall resection with removal of cancerous lung
tissue: for cancers that have invaded the chest wall
Radiation treatment
 Useful in controlling the neoplasm that can not be
surgically removed.
 Used to reduce the size of the tumor
 May help to remove the symptoms like cough, chest
pain, dyspnea and hemoptysis etc.
Chemotherapy
Is used to alter tumor growth and to treat the patient with
metastasis.
 Non small cell:
 Two drug regimen.
 Cis/Carbo platin + 1 other
(Taxol/Taxotere/Gemcitabine)
 Small cell:
 Cisplatin / Etoposide
Contd..
Other drugs involved like-
 Etoposide
 Paclitaxel
 Cyclophosphamide
 Doxorubicin
 Vinblastin
Side effects of treatments
SURGERY RADIATION CHEMOTHERAPY
Pain fatigue Anemia,
thrombocytopenia
Hemotomas Decreased nutritional
intake
Fatigue
Hemmorhage Radiodermatitis Alopecia
Altered respiratory
function
Decreased
hematopoietic function
Cold, pale skin
Risk for atelectasis,
pneumonia, hypoxia
Risk for Pneumonitis,
esophagitis, cough
Tingling
Risk for DVT Lung fibrosis Irritable
Grief Dizziness, weakness
Complimentary Therapies
 Includes ACUPUNCTURE and MASSAGE and
pharmacological approaches such as vitamins and
herbal medicine.
 These herbal therapies combined with chemotherapy
increases survival in non-small-cell lung cancer by up
to 42%, compared with chemotherapy alone.
Complimentary Therapies cont…
 Foods: Green tea, Garlic, Fish Oil,
Lactobacillus.
Complimentary Therapies cont’d
 Mind-body: help to reduce anxiety, mood
disturbance, or chronic pain in cancer patients
(audiotapes, videotapes, books, music,
relaxation, yoga, meditation).
 Acupuncture
 Hypnosis
 Massage therapy
Prognostic Factors
The best estimate on how a patient will do
based on:
*Type of cancer cells
*Size or location of the tumor
*Stage of the cancer at the time of diagnosis
*Age of the person
*Gender
*Results of blood or other tests
*A persons specific response to treatment
*Overall health and physical condition
Prevention: Primary
 Avoid the use of tobacco smoke
 Know environmental carcinogens that increase risk
 Chemoprevention:
 Consuming Vit. A, Vit E,, Vit C.
Prevention: Secondary
 Aim is to early diagnose high risk populations via
screening
 Chest X-Ray, MRI, CT scans, sputum cytology
Prevention: Tertiary
 Targeted at people who survived a cancer disease
 Assists them to retain an optimal level of functioning
regardless of their potential debilitating disease
Nursing assessment
 Subjective data-
 Past health history
 Exposure to smoke, air born carcinogens, any
respiratory diseases and pollutants
 Nutritional habbits
 Symptoms like anorexia, nausea , vomiting, cough
and hemoptysis.
Contd..
 Objective data-
 Vitals monitoring
 Respiratory-assess for wheezing, stridor, hoarseness,
pleural effusion
 CVS- assess for cardiac temponade, dysrhythmias,
pericardial effusion
 Findings- chest X- ray, MRI, CT scan, CBC.
Nursing Diagnoses
1. Ineffective breathing pattern r/t loss of
adequate ventilation as evidenced by
overexertion of pt. during respiration.
2. Impaired gas exchange r/t excessive or thick
secretions or r/t decreased passage of gases
between alveoli of lungs and vascular system
as evidenced by decreased SPo2 level of pt.
3. Chronic pain related to Stage IV NSCLC diagnosis
as evidenced by client reporting “pain in right chest
and lower ribs”.
4. Risk of infection related to altered immune system
secondary to effects of cytotoxic drugs as evidenced
by side effects of the drug/chemotherapy.
5. Risk for disturbed self concept related to changes in
lifestyle.
 Nausea related to effects of chemotherapy as
evidenced by
client reporting feeling nauseated.
 Risk for deficient fluid volume related to
gastrointestinal fluid loss secondary to vomiting.
 Fatigue related to chemotherapy secondary to stage IV
NSCLC as evidenced by client reporting he “ no
longer has the energy to play with his grandchildren or
visit his friends”.
Ineffective breathing pattern
 Teach patient about deep breathing exercises
 Encourage alternating activity with rest periods
 Chest physiotherpy
 Suctioning
 Bronchodilator medication
 O2 administration, if required
Impaired gas exchange
 Instruct the patient to stop smoking
 Semi-fowler position
 Administered antibiotics as prescribed
 Adequate hydration
 Deep breathing exercises
 Nebulisation
 Suctioning, as required
Chronic pain
 Relaxation techniques
 Diversional therapy
 Frequant massage
 Encourage energy conservation
 Comfortable position
 Education to avoid concern about pharmacological
and non- pharmacological therapies
 Medication , as prescribed.
Risk of infection
 Monitor the client body temp. routinely
 Encourage the patient to do regular ADL like
brushing, bathing, eating, toileting
 Provide a high calorie, high protein diet
 Hand washing before and after taking food
 Antibiotics, as prescribed
Risk of disturbed self concept
 Provide psychological support
 Encourage the family members in caring of the
patient
 Encourage the communication with the patient
 Diversional therapy
 Ask the client to identify personal strenght and
talent.
Risk of deficit fluid volume
 Encourage the patient to take fluids (2-3 l/day)
 Small and frequent diet
 I/V fluid administration, if prescribed
 Intake- output charting
 Administer skin care, apply hydrating lotion
 Weight recording
References
 Brunner and sudderth’s, a textbook of medical- surgical
nursing, smeltzer bare, 10th edition, page no-554-557.
 Lewis’s , a text book of medical surgical nursing, chintamani,
7th edition, page no. 585-588.
 Potter.perry, a text book of fundamental of nursing, 7th
edition, page no. 1066, 865.
 Posther KE, Harpole DH. The surgical management of lung
cancer. Cancer Investigation, 2006;24:56–67.
 National Comprehensive Cancer Network. NCCN Clinical
Practice Guidelines in Oncology: . Accessed at
www.nccn.org/professionals/physician_gls/PDF/nscl.pdf on
March 18, 2013.
Lung cancer

Weitere ähnliche Inhalte

Was ist angesagt? (20)

Staging of cancer
Staging of  cancerStaging of  cancer
Staging of cancer
 
Oncological emergencies
Oncological emergenciesOncological emergencies
Oncological emergencies
 
Colon cancer
Colon cancer Colon cancer
Colon cancer
 
Pleural effusion
Pleural effusionPleural effusion
Pleural effusion
 
Bronchial asthma
Bronchial asthmaBronchial asthma
Bronchial asthma
 
Colorectal cancer
Colorectal cancerColorectal cancer
Colorectal cancer
 
Breast cancer ppt med surg
Breast cancer ppt med surgBreast cancer ppt med surg
Breast cancer ppt med surg
 
Modalities of treatment for cancer
Modalities of treatment for cancerModalities of treatment for cancer
Modalities of treatment for cancer
 
Prostate cancer
Prostate cancerProstate cancer
Prostate cancer
 
Liver cancer
Liver cancerLiver cancer
Liver cancer
 
Cancer of bladder
Cancer of bladderCancer of bladder
Cancer of bladder
 
Lung tumor
Lung tumorLung tumor
Lung tumor
 
LUNG CANCER
LUNG CANCERLUNG CANCER
LUNG CANCER
 
Skin cancers
Skin cancersSkin cancers
Skin cancers
 
Renal cancer
Renal cancerRenal cancer
Renal cancer
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Thyroid cancer
Thyroid cancerThyroid cancer
Thyroid cancer
 
Ovarian Cancer
Ovarian CancerOvarian Cancer
Ovarian Cancer
 
Oral cancer
Oral cancerOral cancer
Oral cancer
 
Rheumatic Heart Disease
 Rheumatic Heart Disease Rheumatic Heart Disease
Rheumatic Heart Disease
 

Ähnlich wie Lung cancer

Ähnlich wie Lung cancer (20)

Lung cancer
Lung cancerLung cancer
Lung cancer
 
Lung cancer
Lung cancerLung cancer
Lung cancer
 
Lung cancer by Dr. Aabidullah Rahimee
Lung cancer by Dr. Aabidullah RahimeeLung cancer by Dr. Aabidullah Rahimee
Lung cancer by Dr. Aabidullah Rahimee
 
LUNG CANCER vandana..pptx
LUNG CANCER vandana..pptxLUNG CANCER vandana..pptx
LUNG CANCER vandana..pptx
 
Presentation by nasir
Presentation by nasirPresentation by nasir
Presentation by nasir
 
Lungcancer
Lungcancer Lungcancer
Lungcancer
 
Lung Cancer presentation final.pdf
Lung Cancer presentation final.pdfLung Cancer presentation final.pdf
Lung Cancer presentation final.pdf
 
Surgery 5th year, 5th lecture (Dr. Ahmed Al-Azzawi)
Surgery 5th year, 5th lecture (Dr. Ahmed Al-Azzawi)Surgery 5th year, 5th lecture (Dr. Ahmed Al-Azzawi)
Surgery 5th year, 5th lecture (Dr. Ahmed Al-Azzawi)
 
4 lung cancer
4 lung cancer4 lung cancer
4 lung cancer
 
Lung cancer.pptx
Lung cancer.pptxLung cancer.pptx
Lung cancer.pptx
 
Non small cell lung cancer I
Non small cell lung cancer INon small cell lung cancer I
Non small cell lung cancer I
 
lung cancer.doc
lung  cancer.doclung  cancer.doc
lung cancer.doc
 
ca lungs.pptx
ca lungs.pptxca lungs.pptx
ca lungs.pptx
 
Lung cancer
Lung cancerLung cancer
Lung cancer
 
Lung Cancer: Disease, diagnosis and treatment
Lung Cancer: Disease, diagnosis and treatmentLung Cancer: Disease, diagnosis and treatment
Lung Cancer: Disease, diagnosis and treatment
 
Lung cancer.
Lung cancer.Lung cancer.
Lung cancer.
 
lung cancer
lung cancer lung cancer
lung cancer
 
Lung Cancer.pptx
Lung Cancer.pptxLung Cancer.pptx
Lung Cancer.pptx
 
2 Solid Tumors1
2 Solid Tumors12 Solid Tumors1
2 Solid Tumors1
 
Lung Cancer
Lung Cancer Lung Cancer
Lung Cancer
 

Mehr von GAMANDEEP

Parathyroid disorders
Parathyroid disordersParathyroid disorders
Parathyroid disordersGAMANDEEP
 
Pheochromocytoma
PheochromocytomaPheochromocytoma
PheochromocytomaGAMANDEEP
 
Disorders of adrenal gland
Disorders of adrenal glandDisorders of adrenal gland
Disorders of adrenal glandGAMANDEEP
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes MellitusGAMANDEEP
 
Special respiratory therapies
Special respiratory therapiesSpecial respiratory therapies
Special respiratory therapiesGAMANDEEP
 
Respiratory failure
Respiratory failureRespiratory failure
Respiratory failureGAMANDEEP
 
Pulmonary embolism1
Pulmonary embolism1Pulmonary embolism1
Pulmonary embolism1GAMANDEEP
 
Pleural effusion
Pleural effusionPleural effusion
Pleural effusionGAMANDEEP
 
Pneumonia seminar presentaation
Pneumonia seminar presentaationPneumonia seminar presentaation
Pneumonia seminar presentaationGAMANDEEP
 
Chest physiotherapy
Chest physiotherapyChest physiotherapy
Chest physiotherapyGAMANDEEP
 
Tuberculosis
TuberculosisTuberculosis
TuberculosisGAMANDEEP
 
Bronchiectases
BronchiectasesBronchiectases
BronchiectasesGAMANDEEP
 
Infection control and safety measures
Infection control and safety measuresInfection control and safety measures
Infection control and safety measuresGAMANDEEP
 
The evolution of nursing
The evolution of nursingThe evolution of nursing
The evolution of nursingGAMANDEEP
 
International classification of disease
International classification of diseaseInternational classification of disease
International classification of diseaseGAMANDEEP
 
Concept of disease causation
Concept of disease causationConcept of disease causation
Concept of disease causationGAMANDEEP
 
Chest injury
Chest injuryChest injury
Chest injuryGAMANDEEP
 
Intracranial pressure measurement
Intracranial pressure measurementIntracranial pressure measurement
Intracranial pressure measurementGAMANDEEP
 

Mehr von GAMANDEEP (20)

Parathyroid disorders
Parathyroid disordersParathyroid disorders
Parathyroid disorders
 
Pheochromocytoma
PheochromocytomaPheochromocytoma
Pheochromocytoma
 
Disorders of adrenal gland
Disorders of adrenal glandDisorders of adrenal gland
Disorders of adrenal gland
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
 
Special respiratory therapies
Special respiratory therapiesSpecial respiratory therapies
Special respiratory therapies
 
Respiratory failure
Respiratory failureRespiratory failure
Respiratory failure
 
Pulmonary embolism1
Pulmonary embolism1Pulmonary embolism1
Pulmonary embolism1
 
Pleural effusion
Pleural effusionPleural effusion
Pleural effusion
 
Pneumonia seminar presentaation
Pneumonia seminar presentaationPneumonia seminar presentaation
Pneumonia seminar presentaation
 
Empyema
EmpyemaEmpyema
Empyema
 
Chest physiotherapy
Chest physiotherapyChest physiotherapy
Chest physiotherapy
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Bronchiectases
BronchiectasesBronchiectases
Bronchiectases
 
Asthma ppt
Asthma pptAsthma ppt
Asthma ppt
 
Infection control and safety measures
Infection control and safety measuresInfection control and safety measures
Infection control and safety measures
 
The evolution of nursing
The evolution of nursingThe evolution of nursing
The evolution of nursing
 
International classification of disease
International classification of diseaseInternational classification of disease
International classification of disease
 
Concept of disease causation
Concept of disease causationConcept of disease causation
Concept of disease causation
 
Chest injury
Chest injuryChest injury
Chest injury
 
Intracranial pressure measurement
Intracranial pressure measurementIntracranial pressure measurement
Intracranial pressure measurement
 

Kürzlich hochgeladen

Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefitssahilgabhane29
 
EYE CANCER.pptx prepared by Neha kewat digital learning
EYE CANCER.pptx prepared by  Neha kewat digital learningEYE CANCER.pptx prepared by  Neha kewat digital learning
EYE CANCER.pptx prepared by Neha kewat digital learningNehaKewat
 
21 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 202421 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 2024Traumasoft LLC
 
Artificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementArtificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementIris Thiele Isip-Tan
 
Blood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptxBlood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptxNagamani Manjunath
 
Calibration and Calibration Curve. lecture notes
Calibration and Calibration Curve. lecture notesCalibration and Calibration Curve. lecture notes
Calibration and Calibration Curve. lecture notesWani Insha
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousKR_Barker
 
ARTHRITIS.pptx Prepared by monika gopal Tutor
ARTHRITIS.pptx Prepared  by monika gopal TutorARTHRITIS.pptx Prepared  by monika gopal Tutor
ARTHRITIS.pptx Prepared by monika gopal TutorNehaKewat
 
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
LARYNGEAL CANCER.pptx  Prepared by Neha KewatLARYNGEAL CANCER.pptx  Prepared by Neha Kewat
LARYNGEAL CANCER.pptx Prepared by Neha KewatNehaKewat
 
Presentation on COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSING
Presentation on  COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSINGPresentation on  COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSING
Presentation on COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSINGKREDASONBANGALORE
 
Hematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of HematinicsHematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of Hematinicsnetraangadi2
 
TEST BANK For Neonatal and Pediatric Respiratory Care, 6th Edition by Brian K...
TEST BANK For Neonatal and Pediatric Respiratory Care, 6th Edition by Brian K...TEST BANK For Neonatal and Pediatric Respiratory Care, 6th Edition by Brian K...
TEST BANK For Neonatal and Pediatric Respiratory Care, 6th Edition by Brian K...mwangimwangi222
 
Diseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptxDiseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptxEMADABATHINI PRABHU TEJA
 
Empathy Is a Stress Response - Choose Compassion instead
Empathy Is a Stress Response - Choose Compassion insteadEmpathy Is a Stress Response - Choose Compassion instead
Empathy Is a Stress Response - Choose Compassion insteadAlex Clapson
 
Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)bishwabandhuniraula
 
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdfAnatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdfhezamzaki1
 
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLiving Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLyons Health
 
Health literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxHealth literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxPamela McKinney
 

Kürzlich hochgeladen (20)

Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefits
 
EYE CANCER.pptx prepared by Neha kewat digital learning
EYE CANCER.pptx prepared by  Neha kewat digital learningEYE CANCER.pptx prepared by  Neha kewat digital learning
EYE CANCER.pptx prepared by Neha kewat digital learning
 
21 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 202421 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 2024
 
Artificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementArtificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes Management
 
Blood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptxBlood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptx
 
SCOPE OF CRITICAL CARE ORGANIZATION
SCOPE OF CRITICAL CARE ORGANIZATIONSCOPE OF CRITICAL CARE ORGANIZATION
SCOPE OF CRITICAL CARE ORGANIZATION
 
Calibration and Calibration Curve. lecture notes
Calibration and Calibration Curve. lecture notesCalibration and Calibration Curve. lecture notes
Calibration and Calibration Curve. lecture notes
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the Curious
 
The Power of Active listening - Tool in effective communication.pdf
The Power of Active listening - Tool in effective communication.pdfThe Power of Active listening - Tool in effective communication.pdf
The Power of Active listening - Tool in effective communication.pdf
 
ARTHRITIS.pptx Prepared by monika gopal Tutor
ARTHRITIS.pptx Prepared  by monika gopal TutorARTHRITIS.pptx Prepared  by monika gopal Tutor
ARTHRITIS.pptx Prepared by monika gopal Tutor
 
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
LARYNGEAL CANCER.pptx  Prepared by Neha KewatLARYNGEAL CANCER.pptx  Prepared by Neha Kewat
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
 
Presentation on COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSING
Presentation on  COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSINGPresentation on  COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSING
Presentation on COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSING
 
Hematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of HematinicsHematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of Hematinics
 
TEST BANK For Neonatal and Pediatric Respiratory Care, 6th Edition by Brian K...
TEST BANK For Neonatal and Pediatric Respiratory Care, 6th Edition by Brian K...TEST BANK For Neonatal and Pediatric Respiratory Care, 6th Edition by Brian K...
TEST BANK For Neonatal and Pediatric Respiratory Care, 6th Edition by Brian K...
 
Diseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptxDiseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptx
 
Empathy Is a Stress Response - Choose Compassion instead
Empathy Is a Stress Response - Choose Compassion insteadEmpathy Is a Stress Response - Choose Compassion instead
Empathy Is a Stress Response - Choose Compassion instead
 
Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)
 
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdfAnatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
 
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLiving Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
 
Health literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxHealth literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptx
 

Lung cancer

  • 3. Organs of respiratiory system  Upper respiratory tracts  Nose  Pharynx  Larynx  Trachea  Lower respiratory tracts  Two bronchi (one bronchus to each lung) Bronchioles and smaller air passage  Two lungs and their covering pleura
  • 4. Normal Physiology Of Respiration  Normal respiration begins by inhaling air through the mouth and nose.  This air flows down into trachea, which divides into the left and right bronchi, and then to the alveoli.  The alveoli are responsible for oxygenating the blood for circulation as well as removing carbon dioxide from the blood.
  • 5. Lung Cancer  Most common cause of cancer death for men and women.  Tobacco use accounts for 87% of lung cancer.  Lung cancer affect primarily in 5 or 6th decade of life.  In 70% of lung cancer patient , disease has spread to distant organs.
  • 6. Definition  Cancer: An abnormal growth of cells which tend to proliferate in an uncontrolled way and, in some cases, to metastasize (spread). Cancer is not one disease. It is a group of more than 100 different and distinctive diseases.
  • 9. Types of Lung Cancer Two main Types of Lung Cancer: Small Cell Lung Cancer (20-25% of all lung cancers) Non Small Cell Lung Cancer (most common ~80%)
  • 10. Small Cell Lung Cancer  Small Cell Lung Cancer is the most aggressive form of lung cancer.  It usually starts in the bronchi and then effects the whole lung.  These cancer cells are small and are considered to be quite aggressive in nature and they have a large growth factors.
  • 11. Contd..  Because of these reasons, at the time of diagnosis, (60% of the time), these tumors have often metastasize to other parts of the body (brain, liver, and bone marrow)  SCLC accounts for 20-25% of all lung cancers.
  • 13. Non Small Cell Lung Cancer  NSCLC is any type of epithelial lung cancer other than small cell lung cancer.  Non-small cell lung Ca usually grows and spreads more slowly than SCLC.
  • 14. Types of NSCL  Squamous cell carcinomas usually arise centrally in larger bronchi  Adenocarcinoma : formed from grandular structure in epithelial tissues (mucus secreting glands) are often found in the periphery of the lungs  Large cell carcinomas can occur in any part of the lung and tend to grow and spread faster than the other two types
  • 15. Squamous Cell Carcinoma  Moderate to poor differentiation  Makes up 30-40% of all lung cancers  More common in males  Most occur centrally in the large bronchi  Uncommon metastasis that is slow effects the liver, adrenal glands and lymph nodes.  Associated with smoking  Not easily visualized on x-ray.
  • 16. Adenocacinoma  Increasing in frequency. Most common type of Lung cancer (40-50% of all lung cancers).  Clearly defined peripheral lesions  Glandular appearance under a microscope  Easily seen on a CXR  Can occur in non-smokers  Slow metastatic in nature  Pts present with or develop brain, Liver, adrenal or bone metastasis
  • 17. Large Cell Carcinomas  Makes up 15-20% of all lung cancers  Poorly differentiated cells  Tends to occur in the outer part (periphery) of lung, invading sub-segmental bronchi or larger airways  Metastasis is slow BUT  Early metastasis occurs to the kidney, liver organs as well as the adrenal glands.
  • 18. Causes and risk factors  Gender  Smoking history Active smoking=85-87% Passive smoking=3-5%  Older age  Presence of airflow obstruction  Genetic predisposition.
  • 19. Cont...  Pollution and occupational exposure  Industry work due to asbestos(heat resistant fibrous).  Lung Disease like T.B  family History  Diet (low in fruits and vegetables)
  • 20. Patho-physiology Carcinogens like smoking, occupational and environmental agents, genetics. Binds with cell’s DNA and damage the cells. Cellular changes and abnormal cell growth occur.
  • 21. Cont... Malignant transformation of pulmonary epithelial cells. Abnormal proliferation of the lung cell. These cells grow slowly and covers the segmental bronchi and lobes of the lung. Non specific inflammatory changes with hypersecretion of mucus, desquamation of the cells.
  • 22. Cont... Lesions formation in the lung’s tissues involving the bronchi, bronchioles or even alveoli Bronchogenic carcinoma.
  • 23. Signs and Symptoms There are two types of signs and symptoms of lung cancer: 1) Localized – involving the lung. 2) Generalized – involves other areas throughout the body if the cancer has spread.
  • 24. Localized Signs and Symptoms  Cough and fatigue  Breathing Problems, stridor  blood in phlegm  Lung infection, hemoptysis  Hoarseness, Hiccups  Weight loss  Chest Pain and tightness  Pleural Effusion
  • 25. Generalized Signs and Symptoms  Bone pain  Headaches, mental status changes or neurologic findings  Abdominal pain, elevated liver function tests, enlarged liver, gastrointestinal disturbances (anorexia, cachexia), jaundice, hepatomegaly  Weight loss
  • 26. Early/late Signs and Symptoms Of Lung Cancer Early Signs Late signs Cough/chronic cough Bone pain, spinal cord compression Dyspnea Chest pain/tightness Hemoptysis Dysphagia Chest/shoulder pain Head and neck edema Recurring temperature Blurred vision, headaches Recurring respiratory infections Weakness, anorexia, weight-loss, cachexia Pleural effusion Liver metastasis/regional spread
  • 27. Diagnostic Tests  CXR  CT Scans  MRI  Sputum cytology  Fibreoptic bronchoscopy  Transthoracic fine needle aspiration
  • 28. Laboratory Tests Blood Tests *CBC- to check red/white blood cell & platelets -to check bone marrow and organ function *Blood Chemistry Test- to assess how organs are functioning such as liver and kidney Biopsy-to determine if the tumor is cancer or not -to determine the type of cancer -to determine the grade of cancer (slow or fast)
  • 30.  Endoscopy  Mediastinoscopy  VATS (video assisted thoracoscopic surgery)
  • 33. Nursing Management for post endoscopic procedures Bronchoscopy Mediastinoscopy VATS Monitor V/S; NPO status maintained until return of gag reflex. (Fever up to 1010F can be expected afterwards). Monitor VS; potential for bleeding, infection and dyspnea; NPO status until return of gag reflex Monitor V/S; potential for bleeding, infection and dyspnea; NPO status until return of gag reflex
  • 34. Post-op complications for those with lung cancer  Airway obstruction, dyspnea, hypoxemia, respiratory failure  Anesthesia side effects (N/V)  Bleeding (hypotension, cardiogenic shock)  Cardiac dysthymias, CHF, fluid overload  Fever, sepsis  Pneumonia  Pneumothorax  Pulmonary embolus  Wound dehiscence  Prolonged hospitalization  Death
  • 35. Cancer Staging Systems  The most common staging system for lung cancer is the TNM System developed by the International Union Against Cancer (UICC).  Guides best course of treatment  Estimates prognosis  It is only useful in staging NSCLC, when surgery is considered.
  • 36. TMN Staging system for Lung Cancer T= Tumors : tumor size, (local invasion) N= Node : node involvement (size and type) M= Metastasis : general involvement in organs and tissues
  • 37. Tumor size  Tx – The tumor size is unknown, or cancer cells are only found in sputum.  T0 – The tumor is present only in the cells lining the airway  T1 – Tumors less than or equal to 3 cm  T2- Tumors size is 4-7 cm.  T3 – Tumors greater than 7 cm T4 – tumor that invades structures in the chest such as the heart, major blood vessels near the heart, the trachea, the esophagus.
  • 38. Nodal involvement  N0 – No nodes are involved.  N1 – The tumor has spread to nearby nodes on the same side of the body.  N2 – The tumor has spread to nodes farther away, but on the same side of the chest.  N3 – The tumor has spread to lymph nodes on the other side of the chest from the original tumor, or has spread to nodes near the collarbone or neck muscles.
  • 39. Metastasis  M0 - The tumor has not spread to distant regions.  M1:  M1a – The tumor has spread to the opposite lung, to the lung lining  M1b – The tumor has spread to distant regions of the body, such as the brain or bones.
  • 40. Staging Stage 1. Tumor is small and localised to lung, no lymph node involvement  A-Tumor <3 cm  B-Tumor >3 cm and invading surrounding local area Stage 2.  A-Tumor <3cm with invasion of lymph nodes.  Tumor >3 cm involving the bronchus and lymph nodes on the same side of chest and tissue of local organs.
  • 41. Contd.. Stage 3.  A. Tumor spread to the nearby structure and regional lymph nodes  B. Tumor involving heart, trachea, esophagus, mediastinum and lymph nodes. Stage 4- distant metastasis
  • 42. Medical Management The three main cancer treatments are: *surgery (lung resections) *Radiation therapy *chemotherapy Other types of treatment that are used to treat certain cancers are hormonal therapy, biological therapy or stem cell transplant.
  • 43. Surgical treatment  Lobectomy: a single lobe of lung is removed  Bilobectomy: 2 lobes of the lung are removed (only on R side)  Sleeve resection: cancerous lobe is removed and segment of the main bronchus is resected  Pneumonectomy: removal of entire lung  Segmentectomy: a segment of the lung is removed  Wedge resection: removal of a small, pie-shaped area of the segment  Chest wall resection with removal of cancerous lung tissue: for cancers that have invaded the chest wall
  • 44. Radiation treatment  Useful in controlling the neoplasm that can not be surgically removed.  Used to reduce the size of the tumor  May help to remove the symptoms like cough, chest pain, dyspnea and hemoptysis etc.
  • 45. Chemotherapy Is used to alter tumor growth and to treat the patient with metastasis.  Non small cell:  Two drug regimen.  Cis/Carbo platin + 1 other (Taxol/Taxotere/Gemcitabine)  Small cell:  Cisplatin / Etoposide
  • 46. Contd.. Other drugs involved like-  Etoposide  Paclitaxel  Cyclophosphamide  Doxorubicin  Vinblastin
  • 47. Side effects of treatments SURGERY RADIATION CHEMOTHERAPY Pain fatigue Anemia, thrombocytopenia Hemotomas Decreased nutritional intake Fatigue Hemmorhage Radiodermatitis Alopecia Altered respiratory function Decreased hematopoietic function Cold, pale skin Risk for atelectasis, pneumonia, hypoxia Risk for Pneumonitis, esophagitis, cough Tingling Risk for DVT Lung fibrosis Irritable Grief Dizziness, weakness
  • 48. Complimentary Therapies  Includes ACUPUNCTURE and MASSAGE and pharmacological approaches such as vitamins and herbal medicine.  These herbal therapies combined with chemotherapy increases survival in non-small-cell lung cancer by up to 42%, compared with chemotherapy alone.
  • 49. Complimentary Therapies cont…  Foods: Green tea, Garlic, Fish Oil, Lactobacillus.
  • 50. Complimentary Therapies cont’d  Mind-body: help to reduce anxiety, mood disturbance, or chronic pain in cancer patients (audiotapes, videotapes, books, music, relaxation, yoga, meditation).  Acupuncture  Hypnosis  Massage therapy
  • 51. Prognostic Factors The best estimate on how a patient will do based on: *Type of cancer cells *Size or location of the tumor *Stage of the cancer at the time of diagnosis *Age of the person *Gender *Results of blood or other tests *A persons specific response to treatment *Overall health and physical condition
  • 52. Prevention: Primary  Avoid the use of tobacco smoke  Know environmental carcinogens that increase risk  Chemoprevention:  Consuming Vit. A, Vit E,, Vit C.
  • 53. Prevention: Secondary  Aim is to early diagnose high risk populations via screening  Chest X-Ray, MRI, CT scans, sputum cytology
  • 54. Prevention: Tertiary  Targeted at people who survived a cancer disease  Assists them to retain an optimal level of functioning regardless of their potential debilitating disease
  • 55. Nursing assessment  Subjective data-  Past health history  Exposure to smoke, air born carcinogens, any respiratory diseases and pollutants  Nutritional habbits  Symptoms like anorexia, nausea , vomiting, cough and hemoptysis.
  • 56. Contd..  Objective data-  Vitals monitoring  Respiratory-assess for wheezing, stridor, hoarseness, pleural effusion  CVS- assess for cardiac temponade, dysrhythmias, pericardial effusion  Findings- chest X- ray, MRI, CT scan, CBC.
  • 57. Nursing Diagnoses 1. Ineffective breathing pattern r/t loss of adequate ventilation as evidenced by overexertion of pt. during respiration. 2. Impaired gas exchange r/t excessive or thick secretions or r/t decreased passage of gases between alveoli of lungs and vascular system as evidenced by decreased SPo2 level of pt.
  • 58. 3. Chronic pain related to Stage IV NSCLC diagnosis as evidenced by client reporting “pain in right chest and lower ribs”. 4. Risk of infection related to altered immune system secondary to effects of cytotoxic drugs as evidenced by side effects of the drug/chemotherapy. 5. Risk for disturbed self concept related to changes in lifestyle.
  • 59.  Nausea related to effects of chemotherapy as evidenced by client reporting feeling nauseated.  Risk for deficient fluid volume related to gastrointestinal fluid loss secondary to vomiting.  Fatigue related to chemotherapy secondary to stage IV NSCLC as evidenced by client reporting he “ no longer has the energy to play with his grandchildren or visit his friends”.
  • 60. Ineffective breathing pattern  Teach patient about deep breathing exercises  Encourage alternating activity with rest periods  Chest physiotherpy  Suctioning  Bronchodilator medication  O2 administration, if required
  • 61. Impaired gas exchange  Instruct the patient to stop smoking  Semi-fowler position  Administered antibiotics as prescribed  Adequate hydration  Deep breathing exercises  Nebulisation  Suctioning, as required
  • 62. Chronic pain  Relaxation techniques  Diversional therapy  Frequant massage  Encourage energy conservation  Comfortable position  Education to avoid concern about pharmacological and non- pharmacological therapies  Medication , as prescribed.
  • 63. Risk of infection  Monitor the client body temp. routinely  Encourage the patient to do regular ADL like brushing, bathing, eating, toileting  Provide a high calorie, high protein diet  Hand washing before and after taking food  Antibiotics, as prescribed
  • 64. Risk of disturbed self concept  Provide psychological support  Encourage the family members in caring of the patient  Encourage the communication with the patient  Diversional therapy  Ask the client to identify personal strenght and talent.
  • 65. Risk of deficit fluid volume  Encourage the patient to take fluids (2-3 l/day)  Small and frequent diet  I/V fluid administration, if prescribed  Intake- output charting  Administer skin care, apply hydrating lotion  Weight recording
  • 66. References  Brunner and sudderth’s, a textbook of medical- surgical nursing, smeltzer bare, 10th edition, page no-554-557.  Lewis’s , a text book of medical surgical nursing, chintamani, 7th edition, page no. 585-588.  Potter.perry, a text book of fundamental of nursing, 7th edition, page no. 1066, 865.  Posther KE, Harpole DH. The surgical management of lung cancer. Cancer Investigation, 2006;24:56–67.  National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: . Accessed at www.nccn.org/professionals/physician_gls/PDF/nscl.pdf on March 18, 2013.